InMode MD Ltd.
Yoqneam, 20692, Israel
NCT Number: NCT03438929
The objective of this clinical study is to evaluate safety and efficiency of Diolase XL blended modes for hair removal. The handpieces tested were a blend of 755nm/810nm and 810nm/1064nm. At least 30 female subjects seeking hair removal treatment will be enrolled. Treatment sites will be o groins and axillae. Study design included 3 treatment sessions 4 weeks apart and follow-up after 3 months.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Yoqneam, 20692, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diolaze XL blended modes diode laser
Time frame: 3 months follow-up
Hair reduction of at least 30% at follow-up visit comparing to baseline count.
Time frame: 3 months follow-up
Observation, assessment and recording of reactions by the investigator.
InMode MD Ltd.
Industry
Clinical Evaluation of Diolaze XL Blended Mode for Hair Removal
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04807205
Benign Vascular Lesion, Hair Removal
San Diego, California, United States
View Trial DetailsNCT01057134
Hair Removal
View Trial DetailsNCT03921814
Hair Removal
Montebello, California, United States
View Trial DetailsNCT03945383
Hair Removal
Miami, Florida, United States
View Trial Details